Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,135,826
  • Shares Outstanding, K 103,796
  • Annual Sales, $ 4,390 M
  • Annual Income, $ 24,280 K
  • 60-Month Beta 1.49
  • Price/Sales 1.15
  • Price/Cash Flow 9.13
  • Price/Book 1.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.89
  • Number of Estimates 5
  • High Estimate 0.91
  • Low Estimate 0.87
  • Prior Year 0.89
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.35 +4.48%
on 11/08/19
55.90 -11.50%
on 10/16/19
-4.47 (-8.29%)
since 10/11/19
3-Month
47.35 +4.48%
on 11/08/19
55.90 -11.50%
on 10/16/19
-1.22 (-2.41%)
since 08/13/19
52-Week
36.26 +36.41%
on 12/24/18
56.34 -12.19%
on 02/25/19
-0.21 (-0.42%)
since 11/13/18

Most Recent Stories

More News
Syneos Health Collaborates with AiCure for Patient Engagement

Syneos Health (SYNH) aims to optimize patient engagement and trial success by partnering with AiCure.

HAE : 119.76 (-0.76%)
NUVA : 72.43 (-0.26%)
GWPH : 111.03 (+1.49%)
SYNH : 49.47 (-0.02%)
Syneos Health to Present at the Jefferies 2019 London Healthcare Conference

Syneos Health(R) (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

SYNH : 49.47 (-0.02%)
Bernadette Connaughton Appointed to Syneos Health Board of Directors

Syneos Health (Nasdaq:SYNH), a leading biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and a Contract Commercial Organization (CCO), today announced the appointment...

ZEAL : 31.60 (+0.49%)
HALO : 17.67 (+5.37%)
SYNH : 49.47 (-0.02%)
Syneos Health and AiCure Announce Partnership to Optimize Patient Engagement and Trial Success

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and AiCure, an AI and advanced data analytics company, today announced a novel strategic partnership to...

SYNH : 49.47 (-0.02%)
SYNH vs. OMCL: Which Stock Should Value Investors Buy Now?

SYNH vs. OMCL: Which Stock Is the Better Value Option?

SYNH : 49.47 (-0.02%)
OMCL : 72.09 (-1.45%)
Syneos Health (SYNH) Tops Q3 Earnings Estimates, Ups EPS View

Syneos Health (SYNH) exhibits robust topline performance in the third quarter, backed by strong segmental growth.

TMO : 300.02 (+1.37%)
NUVA : 72.43 (-0.26%)
RMD : 145.28 (+0.78%)
SYNH : 49.47 (-0.02%)
Syneos Health (SYNH) Surpasses Q3 Earnings Estimates

Syneos Health (SYNH) delivered earnings and revenue surprises of 4.82% and -0.44%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

SYNH : 49.47 (-0.02%)
Syneos Health Reports Third Quarter 2019 Results

Highlights

SYNH : 49.47 (-0.02%)
Syneos Health, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 31, 2019 / Syneos Health, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on October 31, 2019 at 8:00 AM Eastern...

SYNH : 49.47 (-0.02%)
ResMed's (RMD) Q1 Earnings Beat Estimates, Margins Expand

ResMed (RMD) registers growth at CER across its key operating segments in Q1.

SYK : 201.73 (+0.77%)
RMD : 145.28 (+0.78%)
MCK : 145.70 (+0.60%)
SYNH : 49.47 (-0.02%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Bearish.

See More Share

Trade SYNH with:

Business Summary

Syneos Health Inc. is an integrated biopharmaceutical solutions organization. It includes a Contract Research Organization and Contract Commercial Organization to accelerate customer performance to address modern market realities. Syneos Health Inc., formerly known as INC Research Holdings Inc., is based...

See More

Key Turning Points

2nd Resistance Point 50.24
1st Resistance Point 49.85
Last Price 49.47
1st Support Level 48.87
2nd Support Level 48.28

See More

52-Week High 56.34
Last Price 49.47
Fibonacci 61.8% 48.67
Fibonacci 50% 46.30
Fibonacci 38.2% 43.93
52-Week Low 36.26

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar